The characterization of the exposure to immune mediated apoptosis and the regulation of immune cytotoxic activity in the environment of a neoplasm and in decidua

Neuroendocrinology Letters

Volumn 27, Issue 6, 2006, Pages 779-785

  Popiela, Tadeusz J ^a   Klimek, Marek ^a   Wicherek, Lukasz ^a   Dutsch Wicherek, Magdalena ^a   Galazka, Krystyna ^a   Rudnicka Sosin, Lucyna ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Apoptosis; Decidua; Immune cytotoxic activity; Neoplasm

Indexed keywords

METALLOTHIONEIN; TUMOR ANTIGEN;

APOPTOSIS; ARTICLE; CELL INFILTRATION; CYTOTOXICITY; DECIDUA; ENDOMETRIOSIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOCYTOTOXICITY; IMMUNOREGULATION; LYMPH NODE METASTASIS; MALIGNANT NEOPLASTIC DISEASE; METASTASIS POTENTIAL; NOSE POLYP; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STROMA;

EID: 33846461177     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Chatterjee M, Mohapatra S, Ionan A, Bawa G, Ali-Fehmi R, Wang X, Nowak J, Nahhas FA, Lu K, Witkin SS, Fishman D, Munkarah A, Morris R, Levin NK, Shirley NN, Tromp G, Abrams J, Draghici S, Tainsky MA: Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res. 2006; 66:1181-90.
2. Slaughter DP, Southwick HW, Smejkal W: "Field cancerization" in oral stratified squamous epithelium. Cancer. 1953; 6:963-8.
3. Boehm JS, Hahn WC: Understanding transformation: progress and gaps. Curr Opin Genet Develop. 2005; 15:13-7.
4. Forsti A, Louhelainen J, Soderberg M, Wijkstrom H, Hemminki K: Loss of heterozygosity in tumor-adjacent normal tissue of breast and bladder cancer. Eur J Cancer. 2001; 37:1372-80.
5. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972; 26:239-57.
6. Garcia-Olmo D, Garcia-Olmo DC: Functionality of circulating DNA: the hypothesis of genometastasis. Ann N Y Acad Sci. 2001; 945:265-75.
7. Halicka HD, Bedner E, Darzynkiewicz Z: Segregation of RNA and separate packing of DNA and RNA in apototic bodies during apotosis. Exp Cell Res. 2000; 260:248-56.
8. Garcia-Olmo D, Garcia-Olmo DC, Ontanon J, Mertinez E: Horizontal transfer of DNA and the "genometastasis hypothesis". Blood. 2000; 95:724-5.
9. Bianchi DW, LeShane ES, Cowan JM: Large amounts of cell-free fetal DNA are present in amniotic fluid. Clin Chem. 2001; 47:1867-9
10. Lo YMD: Fetal DNA in maternal plasma: biology and diagnostic applcation. Clin Chem. 2000; 46:1903-6.
11. Bianchi DW: Circulating fetal DNA: its origin and diagnostic potential-a review. Placenta. 2004; 18:S93-S101.
12. Gercel-Taylor C, O'Connor SM, Lam GK, Taylor DD: Shed membrane fragment modulation of CD3-zeta during pregnancy: link with induction of apoptosis. J Reprod Immunol. 2002; 56:29-44.
13. King A, Burrows T, Loke YW: Human Uterine Natural Killer Cells. Nat Immun. 1996; 15:41-52.
14. Bulmer JN, Lash GE: Human natural killer cells: a reappraisal. Mol Immunol. 2005; 42:511-21.
15. Shimada S, Kato EH, Morikawa M, Iwabuchi K, Nishida R, Kishi R, Onoe K, Minakami H, Yamada H: No difference in natural killer or natural killer T-cell population, but aberrant T-helper cell population in the the endometrium of women with repeated miscarriage. Hum Reprod. 2004; 19:1018-24.
16. Yamada H, Morikawa M, Kato EH, Shimada S, Kobashi G, Minakami H: Pre-conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am J Reprod Immunol. 2003; 50:351-4.
17. Kitaya K, Yamaguchi T, Honjo H: Central role of interleukin-15 in postovulatory recruitment of peripheral blood CD16 (-) natural killer cells into human endometrium. J Clin Enclocrinol Metab. 2005; 90:2932-40.
18. Roberts M, Lu X, Chegini N: Differential regulation of interleukins II-13 and IL-15 by ovarian steroids, TNF-alfa and TGF-beta in human endometrial epithelial and stromal cells. Mol Hum Reprod. 2005; 11:751-60.
19. Linjawi S, Li TC, Tuckerman EM, Blakemore AI, Laird SM: Expression of interleukin-11 receptor alfa and interleukin-11 protein in the the endometrium of normal fertile women and women with recurrent miscarriage. J Reprod Immunol. 2004; 64:145-55.
20. Yamashita H, Otsuki Y, Matsumoto K, Ueki K, Ueki M: Fas-L, Fas antigen and Bcl-2 expression in human the endometrium during the menstrual cycle. Mol Hum Reprod. 1999; 5:358-64.
21. Clark DA, Arck PC, Chaouat G: Why did your mother reject you? Immunogenetic determinations of the response environmental selective pressure expressed at the uterine level. Am J Reprod Immunol. 1999; 41:5-22.
22. Nakashima M, Sonoda K, Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med. 1999; 5:938-42.
23. Sonoda K, Kaku T, Hirakawa T, Kobayashi H, Amada S, Sakai K, Nakashima M, Watanabe T, Nakano H: The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium. Gynecol Oncol. 2000; 79:424-9.
24. Wicherek L, Popiela TJ, Galazka K, Dutsch-Wicherek M, Oplawski M, Basta A, Klimek M: Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, enclometrial adenocarcinoma and endometrium according to menstrual cycle changes. Gynecol Oncol. 2005; 99:622-30.
25. Iwasaki T, Nakashima M, Watanabe T, Yamamoto S, Inoue Y, Yamanaka H, Matsumura A, Iuchi K, Mori T, Okada M: Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1. Int J Cancer. 2000; 89:488-93.
26. Oshikiri T, Hida Y, Miyamoto M, Hashida H, Katoh K, Suzuoki M, Nakakubo Y, Hiraoka K, Shinohara T, Itoh T, Kondo S, Katoh H: RCAS1 as a tumor progression marker: an independent negative prognostic factor in gallbladder cancer. Br J Cancer. 2001; 85:1922-7.
27. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer. Gynecol Oncol. 2005; 97:772-9.
28. Tsuneizumi M, Emi M, Nagai H, Harada H, Sakamoto G, Kasumi F, Inoue S, Kazui T, Nakamura Y: Overrepresentation of the EBAG9 gene at 8q23 associated with early-stage breast cancers. Clin Cancer Res. 2001; 7:3526-32.
29. Popiela TJ, Wicherek L, Dutsch-Wicherek M, Tomaszewska B, Rudnicka-Sosin L, Klimek M, Nowak W: The Presence of RCAS1 expression in breast cancer of advanced stage. Int J Gynecol Cancer. 2004; 14, Suppl.1:249
30. Dutsch-Wicherek M, Wicherek L, Mak P, Skladzien J: Assessment of RCAS1 expression in selected head and neck diseases. Otorynolaryngologia. 2004; 3:25-8.
31. Matsushima T, Nakashima M, Oshima K, Abe Y, Nishimura J, Nawata H, Watanabe T, Muta K: Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood. 2001; 98:313-21.
32. Dutsch-Wicherek M, Popiela TJ, Wicherek L, Modrzejewski M, Tomaszewska R, Skladzien J: RCAS1 expression in laryngeal and pharyngeal cancer with local lymph node metastasis. In The 5th European Congress of Oto-Rhino-Laryngology Head and Neck Surgery, Papaspyrou S (ed). Bologna, Medimond 5.r.l, 2004, pp.345-8.
33. Enjoji M, Nakashima M, Nishi H, Choi I, Oimomi H, Sugimoto R, Kotoh K, Taguchi K, Nakamuta M, Nawata H, Watanabe T: The tumor -associated antigen, RCAS1, can be expressed in immune-mediated diseases as well as in carcinomas of biliary tract. J of Hepatol. 2002; 36:786-92.
34. Dutsch-Wicherek M, Tomaszewska R, Popiela TJ, Wicherek L, Szywala M, Wierzchowski W, Modrzejewski M, Klimek M, Czekierdowska S, Skladzien J: RCAS1 expression in lymphoid tissue of waldeyer's ring. Pol J Environ Stud. 2005; Suppl.II, 14:73-6.
35. Wicherek L, Dutsch-Wicherek M, Mak P, Klimek M: The Role of RCAS1 and Oxytocinase in Immune Tolerance during Pregnancy. Fetal Diagn Ther. 2005; 20:420-5.
36. Kawano Y, Kaku T, Sonoda K, Hirakawa T, Kobayashi H, Ohishi Y, Nakano H: Expression of RCAS1 in female genital organs. Int J Gynecol Pathol. 2005; 24:330-4.
37. Ohshima K, Nakashima M, Sonoda K, Kikuchi M, Watanabe T: Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege. Clin Exp Immunol. 2001; 123:481-6.
38. Theocharis SE, Margeli AP, Klijanienko JT, Kouraklis GP: Metallothionein expression in human neoplasia. Histhopathology. 2004; 45:103-18.
39. Cherian MG, Jayasurya A, Bay BH: Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res. 2003; 533:201-9.
40. Levadoux-Martin M, Hesketh JE, Beattie JH, Wallace HM: Influence of metallothionein-1 localization on its function. Biochem J. 2001; 355:473-9.
41. Tsangaris GT, Tzortzatou-Stathopoulou F: Metallothionein expression prevents apoptosis: a study with antisense phosphorothioate oligodeoxynucleotides in a human T cell line. Antciancer Res. 1998; 18:2423-33.
42. Jayasurya A, Bay BH, Yap WM, Tan NG: Correlation of Metallothionein expression with apoptosis in nasopharyngeal carcinoma. Br J Cancer. 2000; 82:1198-203.
43. Cai L, Wang GJ, Xu ZL, Deng DX, Chakrabarti S, Cherian MG: Metallothionein and apoptosis in primary human hepatocellular carcinoma from northern China. Anticancer Res. 1998; 18:4667-72.
44. Jin R, Huang J, Tan PH, Bay BH: Clinicopathological significances of Metallothioneins in breast cancer. Pathol Oncol Res. 2004; 10:74-9.
45. Mocchegiani E, Muzzioli M, Giacconi R, Cipriano C, Gasparini N, Franceschi C, Gaetti R, Cavalieri E, Suzuki H: Metallothioneins/PARP-1/ IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech Ageing Dev. 2003; 124:459-68.
46. Sakurai A, Hara S, Okano N, Kondo Y, Inoue J, Imura N: Regulatory role of metalothionein in NF-kappaB activation. FEBS Lett. 1999; 455:55-8.
47. Ioachim EE, Kitsiou E, Carassavoglou C, Stefanaki S, Agnantis NJ: Immunohistochemical localization of metallothionein in endometrial lesions. J Pathol. 2000; 191:269-73.
48. Ioachin E: Immunohistochemical tumor markers in endometrial carcinoma. Eur J Gynaecol Oncol. 2005; 26:363-71.
49. McCluggage WG, Maxwell P, Hamilton PW, Jasani B: High metallothionein expression is associated with features predictive of aggressive behaviour in endometrial carcinoma. Histopathology. 1999; 34:51-5.
50. Barnes NL, Ackland ML, Cornish EJ: Metallothionein isoforms expression by breast cancer cells. Int J Biochem Cell Biol. 2000; 32:895-903.
51. Brown JJ, Xu H, Nishitani J, Mohammed H, Osborne R, Teklehaimanot S, Gill G, Liu X: Potential Biomarkers for head and neck squamous cell carcinoma. Laryngoscope. 2003; 113:393-400.
52. Klimek M, Wicherek L, Galazka K, Tetlak T, Popiela TJ, Kulczycka M, Rudnicka-Sosin L, Dutsch-Wicherek M: Cycle dependent expression of endometrial metallothionein. Neuro Endocrinol Lett. 2005; 26:663-6.
53. Wicherek L, Klimek M, Galazka K: Cycle dependent RCAS1 expression with respect to the immune cells presence and activity Neuro Endocrinol Lett. 2006 In press.
54. Wicherek L, Galazka K, Popiela TJ, Dutsch-Wicherek M, Czekierdowski A, Pabian W, Banas T, Migdal M, Klimek M: Metallothionein expression and infiltration of cytotoxic lymphocytes in uterine and tubal implantation site. J Reprod Immunol. 2006; 70:119-31.
55. Szekeres-Bartho J, Varga P, Pacsa AS: Immunologic factors contributing to the initiation of labor-lymphocyte reactivity in term labor and threatened preterm delivery. Am J Obstet Gynecol. 1986; 155:108-12.
56. Hackmon R, Hallak M, Krup M, Weitzman D, Sheiner E, Kaplan B, Weinstein Y: HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy. Fetal Diagn Ther. 2004; 19:404-9.
57. Wicherek L, Dutsch M, Mak P, Klimek M, Skladzien J, Dubin A: Comparative analysis of RCAS1 level in neoplasms and placenta. Acta Biochim Pol. 2003;50:1187-94.
58. Wicherek L, Klimek M, Czekierdowski A, Popiela TJ, Galazka K, Tetlak T, Gilowski A, Dutsch-Wicherek M: The placental RCAS1 expression during stillbirth. Reprod Biol Endocrinol. 2005; 3:24.
59. Wicherek L, Klimek M, Czekierdowski A, Galazka K, Zabinska-Popiela M, Czekierdowska S, Popiela TJ, Dutsch-Wicherek M: Evidence for changes in RCAS1 expression in maternal immune response during uterine cervix ripening. Polish Journal of Environmental Studies. 2005; 14 (Suppl. 2):391-5.
60. Wicherek L, Klimek M, Dutsch-Wicherek M. The level of maternal immune tolerance and fetal maturity. Neuro Endocrinolo Lett. 2005; 26:561-6.
61. Wicherek L, Klimek M, Dutsch-Wicherek M, Kolodziejski L, Skotniczny K: The molecular changes during placenta detachment. Eur J Obstet Gynecol Reprod Biol. 2006; 125:171-5.
62. Wicherek L, Dutsch-Wicherek M, Galazka K, Banas T, Popiela TJ, Lazar A, Kleinrok-Podsiadlo B: Comparison of RCAS1 and Metallothionein expression and the presence and activity of immune cells in human ovarian and abdominal wall endometriomas. Reprod Biol Endocrinol. 2006;4:41
63. Maeda N, Izumiya C, Kusum T, Masumoto T, Yamashita C, Yamamoto Y, Oguri H, Fukaya T: Killer inhibitory receptor CD158a overexpression among Nk cells in women with endmetriosis is undiminished by laparoscopic surgery and GnRH antagonist treatment. Am J Reprod Immunol. 2004; 51:364-72.
64. Vernet-Tomas Mdel M, Perez-Ares CT, Verdu N, Molinero JL, Fernandez-Figueras MT, Carreras R: The endometria of patients with endometriosis show higher expression of class I human leukocyte antigen than the endometria of healthy women. Fertil Steril. 2006; 85:78-83.
65. Wicherek L, Klimek M, Skret-Margielo J, Czekierdowski A, Banas T, Kraczkowski J, Sikora J, Nowak A, Skret A, Basta A: The obstetrical history in patients with Pfannestiel scar endometrioma- an analysis of 81 patients. Gynecol Obstet Investig. 2006. In Press.
66. Wicherek L, Galazka K, Dutsch-Wicherek M, Migdal M, Tetlak T, Klimek M: The presence of RCAS1 positive macrophages in ovarian endometriosis. Eur J Obstet Gynecol Reprod Biol. 2005; Suppl. 1:S44.
67. Dutsch-Wicherek M, Popiela TJ, Klimek M, Rudnicka-Sosin L, Wicherek L, Oudinet JP, Skladzien, Tomaszewska R: Metallothionein stroma reaction in tumor adjacent healthy tissue in head and neck squamous cell carcinoma and breast adenocarcinoma. Neuro Enclocrinol Lett. 2005; 26: 567-74.
68. Popiela TJ, Rudnicka Sosin L, Wicherek L: Metallothionein and RCAS1 expression in comparison to immunological cells activity in breast cancer. Gynecol Oncol. 2006; In Press.
69. Sanchez-Segura A, Brieva JA, Rodriguez C: T lymphocytes that infiltrate nasal polyps have a specialized phenotype and produce a mixed TH1/TH2 pattern of cytokines. J Allergy Clin Immunol. 1998; 102:953-60.
70. Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K: Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol. 1997; 158: 3902-8.
71. Dutsch-Wicherek M, Tomaszewska R, Strek P, Wicherek L, Skladzien J:The analysis of RCAS1 and DFF-45 expression in nasal polyps with respect to immune cells infiltration. BMC Immunol. 2006; 7:4.
72. Chiou SH, Sheu BC, Chang WC, Huang SC, Hong-Nerng H: Current concepts of tumor-infiltrating lymphocytes in human malignancies. J Reprod Immunol. 2005; 67:35-50
73. Sheu BC, Lin RH, Lien HC, Ho HN, Hsu, SM Huang SC: Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J Immunol. 2001; 167:2972-8.
74. Chang WC, Huang SC, Torng PL, Chang DY, Hsu WC, Chiou SH, Chow SN, Sheu BC: Expression of inhibitory natura killer receptors on tumor-infiltrating CD8+ T lymphocyte lineale in human endometrial carcinoma. Int J Gynecol Cancer. 2005; 15:1073-80.
75. Ponte M, Cantoni C, Biassoni R, Tradori-Cappai AT, Bentivoglio G Vitale C, Bertone S, Moretta A, Moretta L, Mingari MC: Inhibitory receptors sensing HLA-G1 molecules. Proc Natl Acad Sci USA. 1999; 96:5674-9.
76. Bainbridge D, Ellis S, Le Bouteiller P, Sargent I: HLA-G remains a mystery. Trends Immunol. 2001; 22:548-52.
77. Sheu BC, Lin RH, Ho HN, Huang SC: Down-regulation of CD25 expression on the surface of activated tumor-infiltrating lymphocytes in human cervical carcinoma. Hum Immunol. 1997; 56:39-48
78. Ho HN, Chao KH, Chen CK, Yang YS, Huang SC: Activation status of T and NK cells in the endometrium throughout menstrual cycle and normal and abnormal early pregnancy. Hum Immunol. 1996; 49:130-6.
79. Saito S, Umekage H, Nishikawa K, Morii T, Narita N, Enomoto M, Sakakura S, Harada N, Ichijo M, Morikawa H: Interleukin 4 (IL-4) blocks the IL-2- induced increased in natural killer activity and DNA synthesis of decidual CD16, CD56bright NK cells by inhibiting expression of the IL-2 receptor alpha, beta and gamma. Cell Immunol. 1996; 170:71-7.
80. Ohshima K, Muta K, Nakashima M, Haraoka S, Tutiya T, Suzumiya J, Kawasaki C, Watanabe T, Kikuchi M: Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion. Int J Cancer. 2001; 93:91-6.
81. Enjoji M, Kotoh K, Nakashima M, Yoshimoto T, Miyagi Y, Kohijma M, Nakamuta M: RCAS1-expressing macrophages in inflammatory liver diseases. Liver Int. 2006;26:358-67.